Anne Goubier, D.V.M., Ph.D.

Anne Goubier, D.V.M., Ph.D.SVP Research & Early Development

Anne Goubier, D.V.M., Ph.D., is Senior Vice President, Research & Early Development at Molecular Partners. Anne brings two decades of biotech experience in drug discovery and drug development. She joined Molecular Partners in 2020 and oversees the Biology department, covering the path from target discovery to clinical pharmacology. Prior to joining Molecular Partners, Anne was CSO of Blackbelt Therapeutics, a company she co-started and which was focused on cancer immune metabolism. Before that, she was VP Immunology at Tusk Therapeutics, leading the science and more specifically the development of a first in class non IL-2 blocking CD25 antibody which was acquired by Roche Pharma in 2018. Before Tusk, Anne has held science leadership position in PX Biosolutions, Genticel and Merial. She obtained her doctorate in veterinary medicine from Nantes Veterinary school and her Ph.D. from University Lyon I.